Literature DB >> 12124166

EGF receptor activation by heterologous mechanisms.

Kermit L Carraway1, Colleen Sweeney.   

Abstract

A myriad of growth factor-dependent and -independent mechanisms for activating the EGF receptor and the related ErbB receptors underscore the importance of receptor inhibitors in the treatment of some solid tumors.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12124166     DOI： 10.1016/s1535-6108(02)00076-4

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  7 in total

1.  Long-range signal transmission in autocrine relays.

Authors:  Michal Pribyl; Cyrill B Muratov; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

2.  Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells.

Authors:  Shinan Li; Pham Ngoc Khoi; Hong Yin; Dhiraj Kumar Sah; Nam-Ho Kim; Sen Lian; Young-Do Jung
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

3.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

4.  Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.

Authors:  Darren C Tomlinson; Fiona R Lamont; Steve D Shnyder; Margaret A Knowles
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

5.  Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.

Authors:  Darren C Tomlinson; Margaret A Knowles
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 6.  The role of histone lysine demethylases in cancer cells' resistance to tyrosine kinase inhibitors.

Authors:  Jasmine Cassar White; Perla Pucci; Francesco Crea
Journal:  Cancer Drug Resist       Date:  2019-06-19

Review 7.  Mechanisms of receptor tyrosine kinase activation in cancer.

Authors:  Zhenfang Du; Christine M Lovly
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.